Does such platelet serotonin/NAS/TrkB activation not only increase survival and proliferation of cancer stem-like cells, but also increase macrophage TGFβ, thereby driving wider changes compatible with tumor survival, such as the induction of tolerogenic dendritic cells? Here, TGFB1 is linked to cancer.